Stockreport

Curis Provides Third Quarter 2025 Business Update [Yahoo! Finance]

Curis, Inc.  (CRIS) 
Last curis, inc. earnings: 11/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.curis.com
PDF Nov. 6, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule [Read more]